8-azidoadenosine

Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

1.	Neoplasms (Cancer) 08/31/1992 - "One compound, 8-azidoadenosine, inhibits CDP reduction in cytosolic extracts from cancer cells. " 07/01/1983 - "The photoaffinity labeling of the regulatory subunits of adenosine cyclic 3':5'-monophosphate-dependent soluble protein kinases with an adenosine cyclic 3':5' monophosphate analogue, 8-azidoadenosine cyclic 3':5'-monophosphate (8-N3-cAMP) was compared in normal prostates and prostatic (Dunning) tumors. "
2.	Neuroblastoma 11/01/1981 - "The induction of differentiation of N-18 mouse neuroblastoma cells, initiated either by adding dibutyryl adenosine cyclic 3':5'-monophosphate to the growth medium or by culturing cells in medium supplemented with 1% fetal calf serum, led to a 3-fold increase in the amount of 8-azidoadenosine cyclic 3':5'-[32P]monophosphate incorporated into Rl, when assayed in vitro. "
3.	Adenoma (Adenomas) 06/01/1984 - "The abilities of cyclic adenosine 3':5'-monophosphate (cAMP) and cyclic 8-azidoadenosine 3':5'-[32P]monophosphate (8-N3-[32P]cAMP) to bind to the regulatory subunit (RII) of the type II cAMP-dependent protein kinase isozyme and to cause subsequent dissociation of the holoenzyme were compared in extracts from adult and neonatal mouse lung and lung adenoma. "

1.	Cyclic AMP (AMP, Cyclic)
2.	Holoenzymes
3.	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)
4.	Bovine Serum Albumin
5.	Protein Kinases (Protein Kinase)
6.	Isoenzymes
7.	Cytidine Diphosphate (CDP)
8.	Adenosine (Adenocard)